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Abstract 
 Introduction: High proportions of E. coli and Klebsiellae isolates at 
Komfo Anokye Teaching Hospital (KATH) have developed resistance to the 
commonly prescribed antimicrobial drugs, but the cause of which is 
unknown.  Detailed data upon which to advocate control interventions are 
scanty. This study determined the prevalence of ESBL Klebsiellae and E. 
coli at KATH, so as to establish the linkage (if any) between ESBL 
production and drug resistance to antimicrobials drugs at the Komfo Anokye 
Teaching Hospital. 
Method: 405 isolates consisting of 156 E. coli strains and 234 Klebsiella 
pneimoniae and 15 Klebsiella oxytoca were collected and tested for their 
antimicrobial susceptibility, ESBL production and the ESBL genotypes were 
determined by PCR.  
Results: High proportions of isolates were resistant to the β-lactam 
antibiotics with ampicillin recordeing 391 (91.7%) resistance followed by 
cefpodoxime 299 (73.8%), cefuroxime 286 (70.6%), ceftriaxone 224 
(55.3%) and then cefotaxime 195 (48.1%). Proportion of isolates resistant 
non β-lactams tested ranged from 61% - 79%. ESBL producers had higher 
resistance proportions than non-ESBL producers. ESBL prevalence range 
from 49.4% in E coli, 61.5% in Klebsiella kpeumoniae to 86.7% in 
Klebsiella oxytoca.  ESBL genotypes TEM, CTX-M were found in 151(64.5) 
isolates while 70(29.9) acquired the three ESBL genotypes.  
Conclusion: The widespread prevalence of ESBL producing E. coli and 
Klebsiellae call for immediate intervention strategies to prevent further 
spread. Training of laboratory personnel on phenotypic testing of ESBLs in 
addition to training clinical staff and prescribers on ESBL issues are 
advocated. 
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Introduction 
 Extended Spectrum B-lactamases (ESBLs) are enzymes that evolved 
with the capacity to degrade β-lactam antibiotics. They also have extended 
action against non-β-lactam antibiotics such as the aminoglycosides, 
tetracyclines, chloramphenicol and quinolones (Shaikh et al., 2015).  ESBLs 
have been found originally among the Klebsiella pneumoniae, and 
Escherichia coli, but have now been detected among various members of the 
family Enterobacteriaceae (Lahlaoui et al., 2014) because they are able to 
spread from one organism to another (Souverein et al., 2016). ESBLs have 
evolved from plasmid-encoded enzyme families of Temoniera (TEM), 
Sufhydryl variable (SHV) and Oxacillin (OXA) (Kuster et al., 2010; Søraas 
et al., 2013). CTX-M evolved directly with the introduction of cefotaxime 
into clinical use. These families and their variants have remained the most 
prevalent ESBL types (Sarma and Ahmed, 2010).  High proportions of E. 
coli and Klebsiellae isolates at Komfo Anokye Teaching Hospital (KATH) 
have developed resistance to the commonly prescribed antimicrobial drugs, 
but the cause of this high resistance is not known.  So detailed data upon 
which antimicrobial resistance control or intervention strategies are to be 
instituted at KATH are scanty. This study therefore investigated the 
prevalence of ESBL Klebsiellae and E. coli at KATH. It also established the 
linkage between ESBL production and the resistance phenotypes of the 
isolates to antimicrobials drugs. 
 
Materials and methods 
 Non-repeat isolates of 156 E. coli, 234 Klebsiella pneumoniae and 15 
Klebsiella oxytoca were collected from a variety of clinical specimens 
namely, blood, urine, sputum and miscellaneous samples (body fluid 
aspirates, wound and pus). The bacteria were identified on single colony 
taken from agar plates. The identification involved pre-screening for typical 
E. coli growth and lactose fermenting characteristic on MacConkey agar and 
followed by Gram stain (Gram negative rods), and indole and methyl red 
positivity, citrate negative, and Voges-Proskauer test negative. The 
Klebsiellae characteristics included Gram negative reaction, indole 
negativity and also methyl red, citrate test and Voges-Proskauer test 
positivity in addition to other protocols for identification of enterobacteria.  
Isolates so identified were then confirmed using the API 20E identification 
systems (bioMerieux SA, Marcy l’Etoile, France).  
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Ethical considerations 
 The culture collection was done at KATH between 2008 and 2010 
after obtaining ethical clearance from joint Committee on Human Research 
Publications and Ethics of the School of Medical Sciences and the Komfo 
Anokye Teaching Hospital. 
 
Antimicrobial susceptibility testing of the isolates 
 The antimicrobial sensitivity of each of the isolates was determined 
using the disc diffusion method according to the Clinical and Laboratory 
Standards Institute (CLSI, 2007).  
 
ESBL Phenotype detection  
 The isolates were first screened for ESBL production and then 
confirmed. 
 
Screening  
 ESBL production by the isolates was determined by inoculating 
Muller-Hinton agar with overnight culture with a turbidity of 0.5 Macfarland 
standard (Dade Microscan turbidity meter, CA, USA) using cefotaxime 
(30µg) and cefpodoxime (10µl). An isolate obviously resistant to 
cefpodoxime (zone diameter ≤25mm) and/or to cefotaxime (zone diameter 
≤29mm) was reported as suspect in the screening test for ESBL production.  
 
Confirmatory test for ESBL production 
 Isolates that were positive for ESBL production in the screening tests 
were selected for confirmation of ESBL production by the double disc 
synergy method. Isolates that showed key-hole patterns formed by the zones 
of inhibition between the co-amoxiclave (10μg/10μg) and a cefpdoxime disc 
confirmed ESBL production (CLSI, 2009). Quality control was performed 
on each batch of the antibiotic discs using the following positive ESBL 
control strains: Escherichia coli (TEM3) NCTC 13351, Escherichia coli 
(CTX-M15) NCTC13353 and Klebsiella pneumoniae (SHV-3) NCTC 
165032. Escherichia coli NCTC 10418 was used as ESBL negative control 
organism. 
 
Detection of ESBL genes by PCR  
 Duplex PCR was performed to determine BlaTEM and BlaCTX-M using 
illustra PuReTaq Ready-To-Go™ PCR beads (GE Health Biosciences, 
Pittsburg, PA, USA) in a 25µl reaction volume. The cycling conditions 
employed following the protocol of Monstein and LE (2007) were: 
denaturation at 94oC for 10 min, 30 cycles of denaturation at 94 o C for 1 
min, followed by annealing at 60 oC for 1 min, extension at 72 o C for 1 min 
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and a final extension step at 72oC for 7 min. The BlaSHV failed to amplify 
with the other primer pairs so was determined alone with cycling conditions 
as follows: denaturation at 94 oC for 10 min, 30 cycles of denaturation at 94 
oC for 1 min, followed by annealing at 59 oC for 1 min, extension at 72 oC 
for 1 min and a final extension step at 72 oC for 7 min. The primer pairs 
sequences, sizes and melting temperatures are as provided in Table 1. 
Table 1 BlaCTX-M and BlaTEM and SHV primers employed to determine ESBL genotypes of 
the isolates 
Primer  Name Primer sequence Size 
bp       
TM oC       
Bla-CTX-M 
forward  
Bla-CTX-M 
reverse 
5’ATGTGCAGYACCAGTAARGTKATGGC’3 
5’TGGGTRAARTARGTSACCAGAAYCAGCGG’3 
593 
593 
53 
52 
Bla-TEM forward 
Bla-TEM reverse 
5’-TCGCCGCATACACTATTCTCAGAATGA-3’ 
5’-ACGCTCACCGGCTCCAGATTTAT-3’ 
445 
445 
54 
58 
Bla-SHV forward 
Bla-SHV reverse 
5’-ATGCGTTATATTCGCCTGTG-3’  
5’-TGCTTTGTTATTCGGGCCAA-3’ 
 
747 
747 
45 
45 
TM =Melting Temperature. Source: (Monstein and LE, 2007) Key for Standard Mixed Base 
Symbols: R-A,G;   
Y-C,T; M-A,C; K-G,T; S-C,G; W-A,T;  H-A,C,T; B-C,G,T; V-A,C,G; D-A,G,T(Integrated 
DNA Technologies, Inc , USA) 
 
Results 
 General characteristics of the study population  
 A total of 405 isolates of Klebsiella and Escherichia coli were 
obtained during the sampling period between 2008 and 2010. The 
Klebsiellae were 249 being 61.5% of the isolates, out of which 234 (94.0%) 
were Klebsiella pneumoniae and 15(6.0%) were K. oxytoca and there were 
56 (38.0%) E. coli. 
 
Socio-demographic characteristics of the study population. 
Age 
 The mean age of the patients infected with E. coli alone was 
32.1±26.8 years, Klebsiella pneumoniae alone was 29.4±27.5 years and for 
Klebsiella oxytoca alone it was 47.9±18.8 years. The mean age (±SD) of all 
patients was 30.8±27.2 years. There was significant difference between ages 
of those affected with Klebsiella oxytoca when compared with those with 
Klebsiella pneumoniae (p=0.02), so also there was a significant age 
difference between E. coli patients and Klebsiella oxytoca infected patients 
(P=0.04)  
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Gender  
 More females 212 (52.3%) than males 193 (47.7%) participated in 
this study. Of the 156 patients infected with E. coli 83 (53.2%) were females 
and 73 (46.8) were males. Klebsiella pneumoniae were isolated from 
119/234 (50.9 %) females and 10/15 (66.7%) K. oxytoca isolates were 
obtained from females. There were no significant differences when number 
of patients infected with E. coli, K. pneumoniae, and K. oxytoca were 
compared.  
 
Place (in/out-patient) 
 Samples analyzed came from many places in the hospital with the 
majority 161(39.8%) coming from the Out-Patients Department (OPD). 
There were no significant differences when isolate types and the places 
(MBU, PEU, OPD and others) were compared.  
Table 2 General characteristic of the studied population stratified by enterobacteria isolate 
  
Sample types 
 There were more proportions of E. coli than K. pneumoniae isolates 
obtained from urine (p=0.01).  So also the difference between K. 
pneumoniae and E. coli proportions obtained from sputumwas found to be 
significant. No significant differences were observed amongst the isolates 
obtained from wound when E.coli and K. pneumoniae were compared 
(p=0.4314), and also when E.coli and K.oxytoca were compared. The 
demographic characteristic data are shown in Table 2. 
 Continuous data are presented as mean ± Sd and categorical data 
presented as proportion. Continuous data were compared to each other using 
unpaired t-test whilst categorical data compared to each other using Chi-
square analysis. P valuea = E coli vrs K. pneumoniae, P valueb = E coli vrs 
K. oxytoca and P valuec = K. pneumoniae vrs K. oxytoca, MBU = Mother-
Baby Unit, PEU = Peadiatric-Emergency Unit and OPD = Out patient 
Variables Total (n=405) E coli (n=156) K. pneumoniae (n=234) K. oxytoca (n=15) P valuea P valueb P valuec 
Socio-demographic data 
      Age (yrs) 30.8 ± 27.2 32.1 ± 26.8 29.4 ± 27.5 47.9 ± 18.8 0.3648 0.0467 0.0224 
Female 212 (52.3%) 83 (53.2%) 119 (50.9%) 10 (66.7%) 0.6490 0.3174 0.2348 
Ward 
       MBU 47 (11.6%) 15 (9.6%) 32 (13.7%) 0 (0.0%) 0.2276 0.2086 0.1250 
PEU 58 (14.3%) 18 (11.5%) 38 (16.2%) 2 (13.3%) 0.1947 0.8363 0.7664 
OPD 161 (39.8%) 65 (41.2%) 85 (36.3%) 11 (73.3%) 0.2881 0.0184 0.0043 
Others 139 (34.3%) 58 (37.2%) 79 (33.8%) 2 (13.3%) 0.4884 0.0645 0.1016 
Sample type 
      Blood 109 (26.9%) 37 (23.7%) 71 (30.3%) 1 (6.7%) 0.1521 0.1292 0.0499 
Urine 155 (38.3%) 75 (48.1%) 72 (30.8%) 8 (53.3%) 0.0005 0.6972 0.0655 
Wound 80 (19.8%) 33 (21.2%) 42 (17.9%) 5 (33.3%) 0.4314 0.2785 0.1399 
Sputum 47 (11.6%) 8 (5.1%) 39 (16.2%) 0 (0.0%) 0.0006 0.3690 0.0851 
Others* 14 (3.5%) 3 (1.9%) 10 (4.3%) 1 (6.7%) 0.2052 0.2456 0.6619 
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department, Others = Other wards, and Others* = other samples (ear, pus and 
aspirates). 
 
Antibiotic susceptibility profiles of the isolates. 
 A total of 405 enterobacteria were tested against 11 different 
antibiotics namely cefotaxime, ceftriaxone, cefuroxime, ampicillin, 
cefpodoxime, co-amoxiclav, imipenem, gentamicin, nalidixic acid, 
ciprofloxacin, co-trimoxazole and chloramphenicol. High proportions of 
isolates were resistant to the β-lactam antibiotics with ampicillin recording 
391 (91.7%) followed by cefpodoxime 299 (73.8%), cefuroxime 286 
(70.6%), ceftriaxone 224 (55.3%) and then cefotaxime 195 (48.1%). The 
proportion of isolates resistant to other antibiotics (non β-lactams) tested 
ranged from 61% - 79% (Table 3).  
Table 3 Proportion of Enterobacteria isolates stratified by resistance to antibiotics and ESBL 
genotype 
Data were presented as proportions. P valuea = E. coli vrs K. pneumoniae, P valueb = E coli 
vrs K. oxytoca and P valuec = K. pneumoniae vrs K. oxytoca, ESBL = Extended spectrum 
beta-lactamase.ESBL phenotypes. 
 
 ESBL phenotypes were detected in high proportions in all the isolates 
tested. Generally ESBL production was detected at 234 (57.8%) for the 
isolates. ESBL production was found in 77(49.4%) E. coli, 144(61.5) K. 
pneumoniae and 13(86.7%) K. oxytoca.  Similarly the proportion of E. coli 
producing ESBL were significantly lower than that of K. oxytoca (see Table 
3). 
Variables 
 
Total 
(n=405) 
E. coli 
(n=156) 
K. pneumoniae 
(n=234) 
K. oxytoca 
(n=15) 
P valuea 
 
P valueb 
 
P valuec 
 
β-lactam antibiotic resistance 
      Cefotaxime 195 (48.1%) 61 (39.1%) 125 (53.4%) 9 (60.0%) 0.01 0.11 0.62 
Cefriaxone 224 (55.3%) 66 (42.3%) 146 (62.4%) 12 (80.0%) < 0.01 0.01 0.17 
Cefuroxime 286 (70.6%) 91 (58.3%) 180 (76.9%) 15 (100.0%) < 0.01 0.01 0.04 
Ampicillin 391 (96.5%) 143 (91.7%) 233 (99.6%) 15 (100.0%) < 0.01 0.21 0.78 
Cefpodoxime 299 (73.8%) 101 (64.7%) 183 (78.2%) 15 (100.0%) 0.01 0.01 0.04 
Co-amoxiclav                  90 (57.7%) 272 (67.2%)         169 (72.2%) 13 (86.7%) 0.01 0.01 0.22 
Imipenem     0 (0.0%)      0 (0.0%)         0 (0.0%)           0 (0.0%) NA NA NA 
Non- β-lactam antibiotic resistance 
     Gentamicin 248 (61.2%) 87 (55.8%) 149 (63.7%) 12 (80.0%) 0.11 0.06 0.19 
Nalidixic acid 266 (65.7%) 97 (62.2%) 156 (66.7%) 15 (100.0%) 0.36 0.01 0.01 
Ciprofloxacin 77 (19.0%) 29 (18.6%) 43 (18.4%) 7 (46.7%) 0.95 0.01 0.01 
Cotrimoxazole 249 (61.5%) 140 (89.7%) 195 (83.3%) 14 (93.3%) 0.07 0.65 0.31 
Chloramphenicol 321 (79.3%) 119 (76.3%) 188 (80.3%) 14 (93.3%) 0.33 0.12 0.21 
ESBL phenotype 
       ESBL 234 (57.8%) 77 (49.4%) 144 (61.5%) 13 (86.7%) 0.01 0.01 0.05 
ESBL genotype 
       SHV 76 (32.5%) 32 (41.6%) 36 (25.0%) 8 (61.5%) 0.01 0.17 0.01 
CTX-M 221 (94.4%) 72 (93.5%) 136 (94.4%) 13 (100.0%) 0.77 0.34 0.38 
TEM 225 (96.2%) 74 (96.1%) 138 (95.8%) 13 (100.0%) 0.92 0.46 0.45 
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ESBL Genotypes: 
 BlaCTX-M and BlaTEM genotypes were more prevalent among isolates 
than the BlaSHV. BlaCTX-M prevalence was 94.4% and for BlaTEM was 96.2% 
amongst the isolates. BlaSHV genotypes prevalence was 32.5%, much lower 
than for BlaCTX-M and BlaTEM. BlaSHV prevalence was significantly higher in 
E. coli (32 (41.6%)) than in K. pneumoniae (36 (25.0%)) (p=0.0050). The 
BlaSHV prevalence in E. coli was again significantly higher than among K. 
oxytoca and K. pneumoniae (p=0.0050). The prevalences of both BlaCTX-M 
and BlaTEM genes were high (above 90%) in E .coli 72 (93.5%).  
 
Socio-demographic characteristics of the study population and ESBL 
production 
 The socio-demographic characteristics of the patients from whom 
samples were taken and antibiotic resistance prevalence were stratified by 
ESBL phenotype (Table 4). The mean age of the patients infected with 
ESBL was 31.1±27.4 whilst the non-ESBL infected patients had mean age of 
30.4±26.9. There was no significant difference between proportion of female 
patients infected with ESBL and the male patients. ESBL prevalence levels 
among the wards were also determined. The Out-Patient Department (OPD) 
with prevalence 39.7% was the highest. The prevalence of ESBL phenotypes 
in all the wards ranged from 12.3% to 39.7%. The differences were all not 
significant when compared with prevalence of non-ESBL isolates (Table 4).  
 
ESBL production of the isolates as a predictor of antimicrobial 
resistance 
 Antimicrobial resistance for ESBL positive isolates and the non-
ESBL phenotypes were compared to determine whether ESBL production 
influenced the antimicrobial resistance prevalence. With exception of 
imipenem, to which all isolates were sensitive, significantly higher 
proportions of ESBL-producers were resistant to the antibiotics tested 
(P=0.0001) with details shown in Table 4. 
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Table 4 Socio-demographic characteristic, sample type, ward and antibiotic resistance in 
relation to ESBL phenotype. 
 
Continuous data were presented as mean ± Sd and categorical data presented as 
proportion. Continuous data were compared to each other using unpaired t-test whilst 
categorical data compared to each other using Chi-square analysis. MBU = Mother-Baby 
Unit, PEU = Peadiatric-Emergency Unit and OPD = Out-patient department, Others = 
Other wards, and Others* = other samples (ear, pus and aspirates). 
 
ESBL distribution in sample types 
 ESBL prevalence was determined for the sample types tested for the 
234 ESBL phenotypes. Urine isolates recorded a significant (p= 0.01) 
Variable 
 
ESBL 
(n=234) 
Non-ESBL 
(n=171) 
P value 
 
Socio-demographic data  
 Age (yrs) 31.1 ± 27.4 30.4 ± 26.9 0.81 
Female 120 (51.3%) 92 (53.8%) 0.61 
Ward 
   MBU 84 (35.9%) 55 (32.2%) 0.43 
PEU 29 (12.3%) 18 (10.5%) 0.56 
OPD 93 (39.7%) 78 (45.6%) 0.23 
Others 38 (16.2%) 20 (11.7%) 0.19 
Sample type 
  Blood 64 (27.4%) 45 (26.3%) 0.81 
Urine 101 (43.2%) 54 (31.6%) 0.01 
Wound 41 (17.5%) 39 (22.8%) 0.18 
Sputum 24 (10.3%) 23 (13.5%) 0.32 
Others* 4 (1.7%) 10 (5.8%) 0.02 
β-lactam antibiotic resistance 
 Cefotaxime 170 (72.6%) 25 (14.6%) < 0.01 
Ceftriaxone 185 (79.1%) 39 (22.8%) < 0.01 
Cefuroxime 212 (90.6%) 74 (43.3%) < 0.01 
Cefpodoxime 214 (91.5%) 85 (49.7%) < 0.01 
Ampicillin 231 (98.7%) 160 (93.6%)    0.01 
Co-amoxiclav        190 (81.2%)                83 (48.5%) < 0.01 
Imipenem 0 (0.0%)    0 (0.0%) NA 
Non-β-lactam antibiotic resistance 
  Gentamicin 176(75.2%) 72 (42.1) < 0.01 
Nalidixic acid 183(78.2%) 85 (49.7%) < 0.01 
Ciprofloxacin 69(29.5%) 8 (4.7%) < 0.01 
Co-trimoxazole 218(93.2%) 131 (76.6%) < 0.01 
Chloramphenicol 206(88.0%) 116 (67.8%) < 0.01 
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prevalence of 101 (43.2%), compared to non-ESBL isolates (54 (31.6%) 
(Table 3).  
 Some of the isolates had multiple genes, where both BlaCTX-M and 
BlaTEM were found in 151(64.5%) of the isolates, but there were no isolates 
with BlaSHV and BlaCTX_M. All the three genes (BlaSHV, BlaCTX-M and BlaTEM) 
were found in 70 (29.9%) of the isolates (Table 5).  
Table 5 Prevalence of multiple ESBL genotypes and their distribution among the isolates. 
  
Discussions 
 This study has demonstrated high prevalence of ESBLs among 
Klebsiellae and E. coli isolates obtained from clinical samples of both in- 
and out-patients at Komfo Anokye Teaching Hospital (KATH). With the 
exception of imipenem to which no resistant isolates were detected, high 
proportions isolates were resistant to all the other antimicrobials tested. The 
resistance proportions ranged from 48.1% to cefotaxime to 91.7% to 
ampicillin. Klebsiella resistance to ampicillin was 100% because of the 
intrinsic resistance characteristics of Klebsiellae (Zhang et al., 2016). In the 
present study it was found that K. oxytoca isolates were more resistant to the 
antibiotics tested than K. pneumoniae and E. coli. Also the Klebsiellae (K. 
oxytoca and K. pneumoniae) were more resistant than E. coli to the 
antimicrobials tested. These high proportions of isolates to antibiotics have 
been reported and attributed to indiscriminate sale and misuse of antibiotics 
in Ghana over the years  by patients (Newman et al., 2006) and by farmers 
who employ the antibiotics in animal production (Azanu et al., 2016; Tajick, 
2006). Manufacture and sale of substandard antibiotics in many developing 
countries including Ghana (Osei-Safo et al., 2016; Shakoor et al., 1977) 
makes it difficult to prescribe the correct dosage of medicines by health 
professionals. In hospitals most of such drugs may not be identified as 
substandard, so the patient may not be given the correct dosage (Osei-Safo et 
al., 2016; Shakoor et al., 1977), leading to treatment failures and hence 
repeated treatments resulting in sensitizing the bacteria and then causing 
them to become resistant (Blomberg, 2008).  
 Another important factor include poor prescribing practices 
(Newman et al., 2006) where physicians prescribe antibiotics without asking 
No (%) of isolates with multiple ESBL genes (n=234) 
None  Single gene Two genes All three 
genes 
present 
All 
genes 
absent 
CTX-
M only 
SHV 
only 
TEM 
only 
SHV + 
CTX-M 
SHV + TEM CTX-M 
+ TEM 
SHV + 
CTX-M + 
TEM 
4 
(1.7) 
0 5 
(2.1) 
3 
(1.3) 
      0 1 (0.4) 151 
(64.5) 
70 (29.9) 
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for microbiological tests, which are compounded by lack of competent 
personnel to perform antimicrobial sensitivity testing even in teaching 
hospitals where the testing facilities exist. Major antibiotics to which 
resistant bacteria were found include the ampicillin, tetracycline and co-
trimoxazole which are capsules or tablets because they are easy to dispense, 
and administer, so they are the most abused than the injectable antibiotics 
like the gentamicin and the third generation cephalosporins. Meanwhile, 
these antibiotics are the major choices for the treatment of severe infections 
at KATH (Saana et al., 2014) sine qua non for the development of multidrug 
resistance caused by the selection for ESBL genotypes (Barogui et al., 2013). 
Prevalence of ESBL production was detected among the isolates at a 
significantly high level of 57.8%, meaning that more than half of the 
enterobacteria isolates tested produce ESBL.  Ciprofloxacin resistance was 
29.5% in ESBL positive and 4.7% in ESBL-negative isolates and this 
difference was significant (p= <0.01), an indication that ciprofloxacin 
resistance in the isolates was closely associated with ESBLs (Shaikh et al., 
2015). Common co-resistance has been found in ESBL-producing organisms 
to aminoglycosides, fluoroquinolones, tetracyclines, chloramphenicol, and 
sulfamethoxazole-trimethoprim (Bajaj et al., 2016). This is a demonstration 
of the emergence of epidemic clones harbouring several beta-lactamases 
simultaneously (BlaCTX-M, BlaSHV and BlaTEM) and perhaps of other 
mechanisms of resistance. Treatment outcomes for these patients, especially 
with β-lactams, would likely be less satisfactory if the organisms produced 
ESBL (Shaikh et al., 2015). For example, in-vitro susceptible-cefepime 
treatment of ESBL producing E. coli and Klebsiella pneumoniae was 
associated with a failure rate of 23-83% (Projan, 2008). Aminoglycosides, 
sulphonamides and quinolones have been suggested as drugs which can be 
used when in-vitro results show that they are susceptible (Cerceo et al., 
2016). Unfortunately epidemiological studies revealed a strong link between 
fluoroquinolone resistance and ESBL production (Cremet et al., 2011).  
 Kumasi strains have ESBL prevalence of 86.7% in K. oxytoca 
followed by K. pneumoniae (61.5%) and then E. coli (49.4%). The high 
prevalence in K. oxytoca probably explains why ESBLs were first detected 
among the Klebsiellae (Knothe, 1983). More importantly in this present 
study about 30 of the isolates had all genes (SHV, CTX-M and TEM) 
suggesting that other ESBL genotypes might also be present in addition to 
those tested for similar to the studies in Erbil, Iraq (Ahmad and Ali, 2014). 
All the ESBL types were found in the hospital and in the community isolates 
with the BlaCTX-M dominating. It is unclear why BlaCTX-M type enzymes have 
spread much more in Kumasi community and in the hospital than the BlaSHV 
enzyme. Though the risk factors for ESBL acquisition are many e.g. 
cephalosporin administration, faecal carriage etc (Hijazi et al., 2016) it can 
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emerge in the community as a result of cephalosporin intake in the 
community and spread by the unhygienic conditions that prevail in the 
communities. In the Hospital, the spread of an ESBL variant can be 
facilitated by a referral system, where the presence of a single ESBL variant 
in a different centre may be imported by a patient on referral to another 
centre (Rodriguez et al., 2010). This situation can hold for KATH which is a 
tertiary referral centre, receiving patients from many parts of the country. 
 In many parts of Ghana including Kumasi it is common to see 
humans share the same compound with animals such as cattle, sheep and 
goats and fowls. Therefore microbes from humans and animals get into 
contact with one another and may exchange genetic material by conjugation 
(Leverstein-van Hall et al., 2011; Rodriguez-Villalobos et al., 2010), 
resulting in some isolates acquiring more than one gene type (Rodriguez-
Villalobos et al., 2010) a situation found at KATH. This warrants future 
surveillance studies at KATH, because treatment of these multi-drug-
resistant organisms is a therapeutic challenge but so far there are no clear 
data in the Hospital morbidity and mortality resulting from treatment 
failures. 
 
Conclusion 
 This study detected high antimicrobial resistance amongst E. coli and 
Klebsiella sp to the commonly prescribed antimicrobial drugs at KATH. 
These resistance levels, perhaps are attributed to ESBL production by these 
isolates obtained from both the community and the hospital wards. 
Ciprofloxacin and imipenem had excellent performance against the isolates 
tested.  All three ESBL genes (BlaCTX-M, BlaTEM and BlaSHV) tested for were 
prevalent among the isolates.  The high levels of antimicrobial resistance and 
the widespread prevalence of ESBL producing E. coli and Klebsiellae 
emphasize the necessity to adopt immediate intervention strategies to prevent 
severe nosocomial infections in the hospital and to continuously monitor 
ESBL spread into the community. Training of laboratory staff on phenotypic 
testing of ESBLs and also training clinical staff and prescribers on ESBL 
issues are warranted and advocated. 
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